These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4631501)

  • 1. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 2. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advantages and limitations of the galactosamine model].
    Decker K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():245-9. PubMed ID: 1029184
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
    Konishi Y; Shinozuka H; Farber JL
    Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 7. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.
    Decker K; Keppler D
    Rev Physiol Biochem Pharmacol; 1974; (71):77-106. PubMed ID: 4375846
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventive effects of 5-fluorouridine and uridine on d-galactosamine-induced liver injury.
    Holstege A; Anukarahanonta T; Yamamoto M; Koch HK; Kattermann R; Lesch R; Keppler D
    Exp Mol Pathol; 1981 Apr; 34(2):170-82. PubMed ID: 6162676
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats.
    Ogoshi S; Iwasa M; Kitagawa S; Ohmori Y; Mizobuchi S; Iwasa Y; Tamiya T
    JPEN J Parenter Enteral Nutr; 1988; 12(1):53-7. PubMed ID: 3125356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Animal disease models--injury, death and various changes of liver cells].
    Taoka Y
    Nihon Rinsho; 1985 Jun; 43(6):1239-50. PubMed ID: 3900478
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 19. Early, reversible plasma membrane injury in galactosamine-induced liver cell death.
    El-Mofty SK; Scrutton MC; Serroni A; Nicolini C; Farber JL
    Am J Pathol; 1975 Jun; 79(3):579-96. PubMed ID: 1137005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.